Howard B. Rosen

Board Member

Mr. Rosen has served on the Talphera Board of Directors since 2008 and was the Chief Executive Officer from 2015 to 2017. He brings more than 25 years of experience in pharmaceutical and biotechnology leadership and strategy to Talphera. Mr. Rosen has served as a lecturer of chemical engineering at Stanford University since 2008 and of management since 2011. He served as Interim President and Chief Executive Officer of Pearl Therapeutics, Inc., from June 2010 to March 2011.

Prior to that, Mr. Rosen was Vice President of Commercial Strategy at Gilead Sciences, Inc., from 2004 to 2008, where his responsibilities included strategic marketing, global brand management, health economics, competitive intelligence, market research, and Gilead’s overall portfolio and business planning. Prior to joining Gilead, he was President of ALZA Corporation, where he was responsible for all aspects of managing ALZA as an independent 1000-person operating company within the Johnson & Johnson Family of Companies. As Vice President of Product Development, Mr. Rosen was responsible for product development activities, portfolio management, and corporate and new product planning.

Mr. Rosen holds a Bachelor of Science degree in chemical engineering from Stanford University, a Master of Science degree in chemical engineering from the Massachusetts Institute of Technology, and a Master of Business Administration degree from the Stanford Graduate School of Business.

Scroll to Top